Viewing Study NCT02073656


Ignite Creation Date: 2025-12-24 @ 11:16 PM
Ignite Modification Date: 2026-02-05 @ 8:44 PM
Study NCT ID: NCT02073656
Status: COMPLETED
Last Update Posted: 2018-11-16
First Post: 2014-02-25
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Efficacy and Safety of Ledipasvir/Sofosbuvir Fixed-Dose Combination for 12 Weeks in Subjects With Chronic Genotype 1 or 4 HCV and HIV-1 Co-infection
Sponsor:
Organization: